Filana Therapeutics, Inc.
FLNA· Nasdaq
FLNAFilana Therapeutics, Inc.
Filed Mar 29, 2019 · 10-K · 88 days after period end · 0001069530-19-000019
derived · Computed from the longer spans the company filed.
| Metric | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures | Q4 2016 | Q4 2015 |
|---|---|---|---|---|
| Net Income | -$678.00K | -$2.42M | -$2.52M | -$4.52M |
| EPS Diluted | — | — | -$0.06 | -$0.10 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Filana Therapeutics, Inc. · CIK 1069530 · Engraved from SEC EDGAR
ended Dec 31, 2018 · filed Mar 29, 2019 · 88 d after period end
